glp-1 obesity drug news today september 29 2025 Alarming rise in weight loss overdoses Trump announces $50/month GLP-1 weight
Description
Inject the Medication: Pinch the skin to form a fold
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.
Prep five to seven cups at once and grab one whenever your appetite window opens
Lilly have launched a Trulicity (dulaglutide), a once-weekly injectable to improve glycaemic control in adults with type II diabetes.
Several new weight loss treatments are in development, including Amgen's MariTide
